|4.||Premature Obstetric Labor (Premature Labor)
|1.||Xiao, Li: 3 articles (04/2015 - 09/2011)|
|2.||Waites, Ken B: 3 articles (04/2014 - 09/2011)|
|3.||Moss, Timothy J M: 2 articles (10/2010 - 09/2010)|
|4.||Dando, Samantha J: 2 articles (10/2010 - 09/2010)|
|5.||Newnham, John P: 2 articles (10/2010 - 09/2010)|
|6.||Nitsos, Ilias: 2 articles (10/2010 - 09/2010)|
|7.||Jobe, Alan H: 2 articles (10/2010 - 09/2010)|
|8.||Knox, Christine L: 2 articles (10/2010 - 09/2010)|
|9.||Waites, Ken: 1 article (04/2015)|
|10.||Cunningham, Scott A: 1 article (04/2015)|
|1.||Azithromycin (Zithromax)FDA LinkGeneric
09/01/2011 - "As an initial step preparatory to future clinical trials to evaluate the clinical efficacy of azithromycin to prevent BPD, the authors characterized the pharmacokinetics, safety, and biological effects of a single intravenous dose of azithromycin (10 mg/kg) in preterm neonates (n = 12) 24 to 28 weeks gestation at risk for Ureaplasma infection and BPD. "
03/01/2014 - "Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model."
|2.||Erythromycin (Erycette)FDA LinkGeneric
10/01/2010 - "This study demonstrates that maternally administered erythromycin does not eradicate chronic, intra-amniotic ureaplasma infections or improve fetal outcomes in an ovine model, potentially because of the poor placental passage of erythromycin."
10/01/2010 - "We examined whether erythromycin would eradicate intra-amniotic ureaplasma infections in pregnant sheep. "
10/01/2010 - "Maternal administration of erythromycin fails to eradicate intrauterine ureaplasma infection in an ovine model."
04/01/2007 - "Preterm infants who needed treatment with erythromycin for ureaplasma infection were given an oral 10 to 15 mg/kg C-(N-dimethyl)-erythromycin dose. "
10/01/2010 - "Erythromycin is the standard antibiotic used for treatment of infection with Ureaplasma spp. during pregnancy; however, maternally administered erythromycin may be ineffective at eliminating intra-amniotic ureaplasma infections. "
|3.||Clarithromycin (Biaxin)FDA LinkGeneric
|4.||Anti-Bacterial Agents (Antibiotics)IBA
05/01/1980 - "For general treatment of genital Mycoplasma infections tetracyclines are usually employed, whereas for Ureaplasma infections erythromycin has been very successful too. "
02/01/2014 - "Regarding antibiotic susceptibility, quinolones are not the best choice for the treatment of ureaplasma infections, while macrolides and tetracyclines are still effective."
04/01/2009 - "We developed a mouse model combining antenatal Ureaplasma infection and postnatal oxygen exposure. "
05/01/2009 - "We propose that Ureaplasma infection initiated in utero and augmented postnatally by exposure to volutrauma and oxygen elicits a sustained, dysregulated inflammatory response in the immature lung that impairs alveolarization, and stimulates myofibroblast proliferation and excessive collagen and elastin deposition. "
|9.||Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
|10.||Interleukin-8 (Interleukin 8)IBA
05/01/2001 - "Mean and maximum concentrations of the inflammatory mediators (IM) interleukin-1 and interleukin-8 were assayed in the tracheobronchial aspirate fluid (TAF) of neonates with perinatal airway infection (Ureaplasma urealyticum, or bacteria), postnatal nosocomial airway infection, or respiratory disease without airway infection from days 1-10 of postnatal age. "
|1.||Transplantation (Transplant Recipients)
04/22/2015 - "We used polymerase chain reaction, specialized culture, and molecular resistance profiling to identify systemic Ureaplasma infection in lung transplant recipients with hyperammonemia syndrome, but did not detect it in any lung transplant recipients with normal ammonia concentrations. "
|2.||Tubal Sterilization (Tubal Ligation)